Budesonide/formoterol and formoterol provide similar rapid relief in patients with acute asthma showing refractoriness to salbutamol
2006

Budesonide/formoterol vs Formoterol for Acute Asthma Relief

Sample size: 115 publication Evidence: moderate

Author Information

Author(s): Bateman ED, Fairall L, Lombardi DM, English R

Primary Institution: University of Cape Town Lung Institute

Hypothesis

To compare the efficacy and safety of budesonide/formoterol with formoterol in treating patients with acute asthma who are refractory to short-acting β2-agonist therapy.

Conclusion

Budesonide/formoterol and formoterol provided similarly rapid relief of acute bronchoconstriction in patients with asthma who showed evidence of refractoriness to a short-acting β2-agonist.

Supporting Evidence

  • Both treatments were well tolerated.
  • FEV1 increased after administration of the study medication in both treatment groups.
  • There were no statistically significant differences between the treatment groups for treatment success or failure.

Takeaway

Both budesonide/formoterol and formoterol help people with asthma feel better quickly, and they work about the same.

Methodology

A randomized, double-blind study comparing budesonide/formoterol and formoterol in 115 patients with acute asthma over 180 minutes.

Limitations

The study may not have captured the full effects of budesonide due to the short observation period and the use of oral prednisolone.

Participant Demographics

Patients aged ≥12 years with a history of chronic severe asthma, predominantly Caucasian, with a mean age of approximately 44 years.

Digital Object Identifier (DOI)

10.1186/1465-9921-7-13

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication